NCT06018311

Brief Summary

The purpose of this study is to determine the feasibility and effects of an adapted Exercising Together, a partnered resistance training program, on the physical and mental health of prostate cancer survivors and their informal caregiver. The Exercising Together program is designed to promote teamwork during supervised group exercise classes delivered remotely through videoconferencing software. The intervention period will be 3-months with a 3-month follow-up.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
58

participants targeted

Target at P25-P50 for not_applicable

Timeline
8mo left

Started Nov 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress79%
Nov 2023Dec 2026

First Submitted

Initial submission to the registry

August 11, 2023

Completed
19 days until next milestone

First Posted

Study publicly available on registry

August 30, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

November 1, 2023

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

March 20, 2026

Status Verified

March 1, 2026

Enrollment Period

3.2 years

First QC Date

August 11, 2023

Last Update Submit

March 17, 2026

Conditions

Keywords

caregiversCancer survivorshipHispanic Men's HealthStrength trainingPilot study

Outcome Measures

Primary Outcomes (4)

  • Acceptability measured by adherence to intervention

    Acceptability will be measured by adherence to the intervention calculated as the total number of classes attended divided by the total possible schedule the patient could attend using descriptive statistics.

    3 months

  • Appropriateness measured by retention rate

    Will be determined as the retention rate- calculated as the number of dyads completing the study versus consented using descriptive statistics.

    3 months

  • Feasibility measured by enrollment rate

    Will be determined as the enrollment rate- the number of dyads enrolled out of those approached and eligible using descriptive statistics.

    3 months

  • Implementation Success - composite measure of acceptability, appropriateness, and feasibility.

    Implementation success is a composite measure that will be measured by a single questionnaire that will determine the extent to which the intervention is considered acceptable, appropriate, and feasible. The single questionnaire will consist of 3 measures that will be summed into one final score, The Acceptability of Intervention Measure (AIM), Intervention Appropriateness Measure (IAM), and Feasibility of Intervention Measure (FIM). Responses from AIM, IAM, and FIM are summary scored with a possible range of 12-60; higher scores indicate greater acceptability, appropriateness, and feasibility.

    3 months

Secondary Outcomes (5)

  • Physical activity

    Physical activity will be measured over a 6 month period. It will be measured at baseline, 3 months, and 6 months.

  • Health-Related Quality of Life (HR-QOL) for the caregiver

    HR-QOL will be measured over a 6 month period. It will be measured at baseline, 3 months, and 6 months.

  • Health-Related Quality of Life (HR-QOL) for the survivor

    HR-QOL will be measured over a 6 month period. It will be measured at baseline, 3 months, and 6 months.

  • Relationship Health

    Relationship Health will be measured over a 6 month period. It will be measured at baseline, 3 months, and 6 months.

  • Objective Physical Function

    Objective Physical Function will be measured over a 6 month period. It will be measured at baseline, 3 months, and 6 months.

Study Arms (1)

Exercising Together

EXPERIMENTAL

Dyads perform partnered exercise over 1 hour, 3 days per week in a supervised, group setting remotely for 3 months.

Behavioral: Exercising together

Interventions

The Exercising Together program is a partnered functional strength training program that encourages participating dyads to interact with one another, verbally and physically, during exercise sessions. In Exercising Together, the survivor and their caregiver will build skills to work as a team. We will incorporate skills that promote and reinforce communication, motivation, and support and use this to guide training of survivor-caregiver dyads to maximize their teamwork during each exercise session. Group sessions are delivered remotely through videoconferencing software and are supervised by two trained exercise instructors. Intervention and assessment is available in English or Spanish.

Exercising Together

Eligibility Criteria

Age18 Years - 99 Years
Sexall(Gender-based eligibility)
Gender Eligibility DetailsPhase 1 was Prostate Cancer Specific; require male biological sex Phase 2 is not sex specific
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Self-identifies as Hispanic
  • Histologically confirmed prostate cancer diagnosis (self-report)
  • Completed primary treatment at least 6 weeks prior at time of enrollment
  • Has an identified caregiver in any relationship role (e.g., spouse, sibling, parent, friend) who can participate with them.
  • \. Identifies as an individual (e.g., family member or friend) who provides unpaid care or support to a participating prostate cancer survivor.
  • ≥18 years of age
  • Understands (ability to read and speak) English or Spanish and able to provide informed consent
  • Meets the American College of Sports Medicine pre-participation screening criteria for exercise
  • Ability to ambulate (with or without assistive devices)
  • Willing to attend study group exercise classes online, complete remote assessments, and answer online surveys
  • Has access to a mobile device with camera and internet.
  • Able to participate in classes at same time as other participating member.

You may not qualify if:

  • Cognitive difficulties that preclude answering the survey questions, participating in the exercise classes or performance tests, or providing informed consent as determined by the professional opinion of the Principal Investigator
  • A medical condition, movement or neurological disorder, or medication use that contraindicates participation in moderate intensity exercise or poses a significant safety concern/risk for the well-being of the participant (e.g., declared pregnancy, poorly controlled diabetes, recent cardiac event, neuromuscular disease, untreated orthostatic hypertension, recent surgery, acute hernia, acute rheumatoid arthritis, severe memory disorders, severe balance disorder, severe hearing or vision impairment)
  • Knowingly unable to attend \>75% of the intervention classes due to conflict with the designated time of day, days of the week, and/or location for the exercise class which they initially enrolled
  • Incapable of providing informed consent, answering survey questions, participating in the intervention, and following directions during performance testing when English or Spanish language is used
  • Unable to be in the same location with participating member during remote exercise classes and performance testing and/or insufficient internet connectivity to support required videoconferencing software
  • Phase 2:
  • Histologically confirmed cancer diagnosis (self-report)
  • Completed primary treatment at least 6 weeks prior at time of enrollment
  • Has an identified caregiver in any relationship role (e.g., spouse, sibling, parent, friend) who can participate with them.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Arizona Cancer Center

Tucson, Arizona, 85719, United States

Location

MeSH Terms

Conditions

NeoplasmsProstatic NeoplasmsMotor ActivityCaregiver Burden

Condition Hierarchy (Ancestors)

Genital Neoplasms, MaleUrogenital NeoplasmsNeoplasms by SiteGenital Diseases, MaleGenital DiseasesUrogenital DiseasesProstatic DiseasesMale Urogenital DiseasesBehaviorStress, PsychologicalBehavioral Symptoms

Study Officials

  • Meghan B Skiba, PhD, MS, MPH, RDN

    University of Arizona College of Nursing Biobehavioral Health Science Division

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 11, 2023

First Posted

August 30, 2023

Study Start

November 1, 2023

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

March 20, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations